Ki-Jun Hwang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ki-Jun Hwang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Tae-Suk Lee
Chonbuk National University
2 shared publicationsBeom -Tae Kim
Chonbuk National University
1 shared publicationBeom-Tae Kim
Chonbuk National University
1 shared publicationChong -Ock Lee
Korea Research Institute of Chemical Technology
1 shared publicationChul-Min Lee
Chonbuk National University
1 shared publicationEun-Young Park
Chonbuk National University
1 shared publication
Latest Publications
- 1 December 2002
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 25 (6) , 781-785
Novel benzoylurea derivatives as potential antitumor agents; synthesis, activities and structure-activity relationships
A series of pyrazoloxyphenyl benzoyl urea derivatives was designed and synthesized for cytotoxic evaluation as potential antitumor agents. The synthetic compounds were evaluated for in vitro cytotoxicity against five human tumor cell lines, including A-549, SKOV-3, SK-MEL-2, XF-498 and HCT-15. Among others, compound 11 exhibited 50~100 times greater antitumor activities than the commercial product, Cisplatin.
- 1 December 2002
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 25 (6) , 781-785
Novel benzoylurea derivatives as potential antitumor agents; synthesis, activities and structure-activity relationships
A series of pyrazoloxyphenyl benzoyl urea derivatives was designed and synthesized for cytotoxic evaluation as potential antitumor agents. The synthetic compounds were evaluated for in vitro cytotoxicity against five human tumor cell lines, including A-549, SKOV-3, SK-MEL-2, XF-498 and HCT-15. Among others, compound 11 exhibited 50~100 times greater antitumor activities than the commercial product, Cisplatin.
- 1 April 2000
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 23 (2) , 112-115
Synthesis of 4,6-dichloro-3-[(1-N-arylaminocarbonyl)-hydrazono]-1,3-dihydro-indole-2-one as a potential NMDA receptor glycine site antagonist
- 1 April 2000
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 23 (2) , 112-115
Synthesis of 4,6-dichloro-3-[(1-N-arylaminocarbonyl)-hydrazono]-1,3-dihydro-indole-2-one as a potential NMDA receptor glycine site antagonist
- 1 February 2000
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 23 (1) , 31-34
Synthesis of 7,8-dichloro-6-Nitro-1H-1,5-benzodiazepine-2,4-(3H, 5H)-dione as a potential NMDA receptor glycine site antagonist
An efficient procedure for the preparation of 7,8-dichloro-6-nitro-1H-1,5-benzodiazepine-2,4-(3H, 5H)-dione(7) as a potential lead compound for the NMDA receptor glycine binding site antagonist, starting from readily available 4,5-dichloro-2-nitroaniline(8), is described. The key step in the synthesis involves the cyclization of malonic ester amide10 to compound11.
- 1 February 2000
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 23 (1) , 31-34
Synthesis of 7,8-dichloro-6-Nitro-1H-1,5-benzodiazepine-2,4-(3H, 5H)-dione as a potential NMDA receptor glycine site antagonist
An efficient procedure for the preparation of 7,8-dichloro-6-nitro-1H-1,5-benzodiazepine-2,4-(3H, 5H)-dione(7) as a potential lead compound for the NMDA receptor glycine binding site antagonist, starting from readily available 4,5-dichloro-2-nitroaniline(8), is described. The key step in the synthesis involves the cyclization of malonic ester amide10 to compound11.